Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 157-160

  Li Volti, S ^a   Di Gregorio, F ^a   Romeo, M A ^a   Cannella, A ^a   Pizzarelli, G ^a   Sciacca, A ^a   Russo, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bone marrow transplantation; HBV vaccine; Immunization; Revaccination; Thalassemia major

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; CHILD; CLINICAL ARTICLE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; REVACCINATION; THALASSEMIA MAJOR;

EID: 0031014132     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700635     Document Type: Article

References (25)

1. Stroffolini T, Pasquini P, Mele A et al. HBsAg carriers among pregnant women in Italy: result from the screening during a vaccination campaign against hepatitis B. Public Health 1988; 102: 329-334.
2. Piazza M, Da Villa G, Picciotti L et al. Mass vaccination against hepatitis B in infants in Italy. Lancet 1988; ii: 1132 (letter).
3. Musumeci S, Di Gregorio F, Fischer A et al. Incidenza dell'antigene Australia (HB Ag) e del relativo anticorpo (HB Ab) in bambini thalassemici siciliani politrasfusi. La Pediatria 1977; 85: 21-33.
4. Atkinson K, Starb R, Prentice RL et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720-731.
5. Neimann P, Wassermann PB, Wentherworth BB et al. Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 1973; 15: 478-488.
6. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V et al. Long-term immunity to measles, mumps and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657-663.
7. Wahrem B, Gahrton G, Linde A et al. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150: 358-365.
8. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1-5.
9. Lum MG. Immune recovery after bone marrow transplantation. Hemat Oncol Clin North Am 1990; 4: 659-675.
10. Pasquini P. Evidenze epidemiologiche della necessità di immunizzazione contro l'epatite B degli adolescenti in Italia. Vaccinazione 2000 1990; 2: 3-4.
11. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia. New Engl J Med 1990; 322: 417-421.
12. De Wilde M, Cabezon T, Herford N et al. Production in yeast of hepatitis B surface antigen by R-DNA technology. Dev Biol Stand 1985; 59: 99-107.
13. Crosnier J, Jungers P, Courouce AM et al. Randomised placebo controlled trial of hepatitis B surface antigen vaccine in French hemodialysed units. I. Medical staff. Lancet 1981; i: 455-459.
14. Winston DJ, Ho WG, Schiffman G et al. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med 1983; 143: 1735-1737.
15. Ljungman P, Fridell E, Lonniqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with live attenuated measles, mumps and rubella vaccine. J Infect Dis 1989; 159: 610-615.
16. Gottlieb DJ, Cryz SJ, Purer CE et al. Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients. Blood 1994; 76: 2470-2475.
17. Engelhard D, Handsher R, Naparstek E et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295-300.
18. McDonald GB, Shulman HM, Walford JL, Spencer GD. Liver disease after human marrow transplantation. Semin Liver Dis 1987; 7: 210-229.
19. Webster A, Brenner MK, Prentice HG, Griffiths PD. Fatal hepatitis reactivation after autologous bone marrow transplantation. Bone Marrow Transplant 1989; 4: 207-208.
20. Locasciulli A, Bacigalupo A, Alberti A et al. Predictability before transplant of hepatic complications following alloceneic bone marrow transplantation. Transplantation 1989; 48: 68-72.
21. Locasciulli A, Bacigalupo A, Van Lint MT et al. Hepatitis B virus infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant 1990; 6: 25-29.
22. Nagler A, Ilan Y, Adler R et al. Successful immunisation of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplant 1995; 15: 475-478.
23. Tilzey AJ, Palmer SJ, Benatvala JE et al. Hepatitis B vaccine boosting among young healthy adults. Lancet 1994; ii: 1438-1439.
24. Goffin E, Horsmans Y, Cornu C et al. Acute hepatitis B infection after vaccination. Lancet 1995; i: 263 (letter).
25. Jilg W, Schmidt M, Deinhardt F, Decline of anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet 1990; i: 173-174 (letter).